Our commitment to innovation remains the key to success in the future especially with regard to the availability of discovery molecules. Looking at the country's needs, we are making sure that our research molecules optimally serve the needs of both doctors and patients.

Our emphasis continues to be on integrated healthcare services and disease management. Our goal is to be consistent in our clinical research strategies in the therapeutic areas of oncology, virology and transplantation.